Figure 8 illustrates the protein networks for the top 30 enriched genes in the prostate cancer-related KEGG pathway. This analysis provides a list of the most significant target proteins with a cutoff p-value < 0.05. For example, our analysis finds that zinc finger protein 16 (ZNF16), which has been shown to have a potential role in DNA damage, and Cisplatin (used as an anticancer drug) prevent the overexpression of this protein [39]. Furthermore, RecQL4 was reported as a novel molecular target for cancer therapy in 2021 [40], with a prognostic role in metastatic tumor samples [41]. This evidence concerns the gene ZNF16 and Familial prostate cancer.